Special ArticleInternational Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
Section snippets
Review of Diagnostic Criteria
The descriptive criteria appear to have stood the test of time and require at most only minor modifications (see below) to bring them into line with recent developments in diagnostic modalities for liver disease generally. The review has, however, revealed that the scoring system requires some adjustments to improve specificity and simplify its use.
There are six published studies in which the scoring system has been applied to sufficient numbers of patients to allow for meaningful evaluation 5.
Presenting clinical and serum biochemical features
The present review has reaffirmed that there are no particular signs, symptoms or liver test abnormalities that are of sufficient specificity to be considered part of the diagnostic criteria (4). Onset is usually insidious, with fatigue, fluctuating jaundice and arthralgia as typical features, but a substantial proportion of patients either have no obvious signs or symptoms of liver disease or have an (occasionally severe) acute presentation 13., 14., 15.. There is often a history of other
Descriptive criteria
The suggested minor modifications to the descriptive criteria are incorporated in Table 4. Histological features that are considered to lack sufficient specificity individually to exclude AIH have been omitted. The previous (4) separate specification for titres of autoantibodies in children is no longer considered necessary but it is noted that lower titres may be significant. Obligatory exclusion of markers of infection with hepatotropic viruses other than hepatitis A, B and C, and a history
Acknowledgements
We gratefully acknowledge the contribution of Dr. Kirsten Boberg in re-analysing her data on primary sclerosing cholangitis patients using the revised scoring system.
References (84)
- et al.
Present status of autoimmune hepatitis in Japan - correlating the characteristics with international criteria in an area with a high rate of HCV infection
J Hepatol
(1997) - et al.
Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis
Hepatology
(1996) - et al.
Subfulminant hepatic failure in autoimmune hepatitis type 1: an unusual form of presentation
J Hepatol
(1997) - et al.
High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis
Gastroenterology
(1995) - et al.
Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential
Kidney International
(1994) - et al.
Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis
Hepatology
(1996) - et al.
Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture
Hepatology
(1996) - et al.
Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis
Gastroenterology
(1994) - et al.
Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis
Gastroenterology
(1993) - et al.
Antiliver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease
Hepatology
(1995)
GBV-C/HGV is not the major cause of autoimmune hepatitis
J Hepatol
Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?
Gastroenterology
Immunologic features and HLA associations in chronic viral hepatitis
Gastroenterology
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on disease profile
Hepatology
Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies
J Hepatol
Autoantibody prevalence in chronic hepatitis B virus infection: effect of interferon alpha
Hepatology
Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during α-interferon therapy
J Hepatol
Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation
Hepatology
A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results
J Hepatol
Natural history of early primary biliary cirrhosis
Lancet
Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases
Am J Gastroenterol
Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis
Hepatology
Primary sclerosing cholangitis with normal alkaline phosphatase activity
Gastroenterology
Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis
J Hepatol
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
Science
Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: summary of recommendations developed by an international working party
Am J Gastroenterol
Terminology of Chronic Hepatitis: International Working Party
Am J Gastroenterol
Meeting Report: International Autoimmune Hepatitis Group
Hepatology
Validation of scoring system for diagnosis of autoimmune hepatitis
Dig Dis Sci
Impact of International Autoimmune Hepatitis Group scoring system in definition of autoimmune hepatitis. An Italian experience
Dig Dis Sci
Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis
J Gastroenterol
The international autoimmune hepatitis score in chronic hepatitis C
J Viral Hep
Natural history, clinical features, and treatment of autoimmune hepatitis
Semin Liver Dis
Recent progress in autoimmune liver disease
Type 1 autoimmune hepatitis is primarily a disease of later life
Q J Med
Diagnostic criteria, clinical manifestations and natural history of autoimmune hepatitis
The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis
Gut
How to diagnose autoimmune hepatitis in systemic lupus erythematosus
Hepatology
Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis
Clin Exp Immunol
Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis
Gut
Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases: high prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis
Clin Microbiol Immunol
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver disease
Hepatology
Cited by (2634)
Liver inflammation activity in patients with autoimmune hepatitis with normal alanine aminotransferase and immunoglobulin G levels
2024, Journal of Translational AutoimmunityIdentifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases
2024, Journal of AutoimmunityAutoimmune Hepatitis: Epidemiology, Subtypes, and Presentation
2024, Clinics in Liver DiseaseAutoimmune Hepatitis: Pathophysiology
2024, Clinics in Liver DiseaseDiagnosis of Autoimmune Hepatitis
2024, Clinics in Liver Disease